Application

17934553 · 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

Filed 2022-09-22 · Pending The official file ↗ · Art unit 1624 · Examiner Madeline E Braun Hard · CPC A61K 31/444 · Dana-Farber Cancer Institute, Inc. · GREENBERG TRAURIG, LLP (BOS)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

31.8 mo

to disposition n/a

Statutes raised

103 112 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.